SAMUEL WAXMAN, M.D.
Osteopathic Medicine at 5 Ave, New York, NY

License number

New York 092748

Personal information

See more information about SAMUEL WAXMAN at radaris.com

Name

Address

Phone

Samuel Waxman, age 88

1158 5Th Ave #15B, New York, NY 10029

Samuel Waxman

166 E 34Th St APT 19A, New York, NY 10016

Samuel Waxman, age 49

211 E 70Th St APT 10B, New York, NY 10021

(212) 879-4686

Samuel Waxman, age 89

1150 5Th Ave, New York, NY 10128

(212) 289-2828

Samuel Waxman, age 88

1158 5Th Ave, New York, NY 10029

(212) 876-7888

Organization information

See more information about SAMUEL WAXMAN at bizstanding.com

SAMUEL WAXMAN, M.D., PC

1150 5 Ave, New York, NY 10128

Industry:

Oncology, Internist

Doing business as:

Samuel Waxman MD

Registration:

Jun 23, 1998

Phone:

(212) 289-2828 (Phone)

Description:

There are 2 doctors at this site. Surgery is not performed at this site.

State ID:

2272366

Business type:

DOMESTIC PROFESSIONAL CORPORATION

Samuel Waxman Md, 1150 5 Ave, New York, NY 10128 (Physical),Samuel Waxman

Samuel Waxman Cancer Research

1150 5 Ave #610, New York, NY 10128

Phone:

(212) 369-2652 (Phone)

Email:

[email protected]

Description:

Non-Profit Organizations

SIC:

8399 - Social Services, Not Elsewhere Classified

Samuel Waxman Cancer Research Foundation

420 Lexington Ave SUITE 825, New York, NY 10170

Industry:

Nonprofit Organization Management, Medical Doctor's Office, Nonclassifiable Establishments, ...

Doing business as:

Samuel Waxman Cancer

Site:

waxmancancer.org, sp.bestflowers.com

Phone:

(212) 867-4502 (Phone)

Description:

The Samuel Waxman Cancer Research Foundation (SWCRF) is dedicated to finding cures for cancer through reprogramming cancer cells, a type of research in which scientists alter cancer cells so they beha...

Founded:

1976

Categories:

Cancer Clinics

Specialties:

We fund innovative cancer research grants that bridge the gap between bench and bedside.

Company size:

1-10 employees

Samuel Waxman Cancer Research

1 Gustave L Levy Pl, New York, NY 10029

Site:

waxmancancer.org

Phone:

(212) 369-2652 (Phone), (212) 426-2273 (Fax)

Executive Director:

Merle Kailas (Executive Director)

SIC:

8399 - Social Services, Not Elsewhere Classified

Company size:

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION

New York, NY

Registration:

Dec 22, 2006

State ID:

77070565

Reg. number:

3397207

Status:

701 - Section 8-accepted

Status date:

Mar 28, 2013

Illustration:

Drawing with word(s)/letter(s)/number(s) in Block form

Attorney:

Mark B. Harrison

Employee:

Frederick M Mandir

Goods & Services:

"cancer research foundation", Promoting public awareness of the need for cancer research, Charitable fundraising services; providing charitable funding of cancer research; financial sponsorship of can...

Owner:

1150 5 Ave, New York, NY 10128

Correspondent:

The Samuel Waxman Cancer Research Founda,420 LEXINGTON AVE,Suite 82 SUITE 825, New York, NY 10170

Samuel Waxman Cancer Research Foundation

1249 5 Ave, New York, NY 10029

Status:

Inactive

Industry:

Civic/Social Association

Members:

Michelle A. Nicholas Associate, inactive,Bridget Stein Associate Director, inactive,Carole Asher Assistant Director, inactive,...

Professional information

Samuel Alexander Waxman, New York NY - Lawyer

Address:

Shearman & Sterling
599 Lexington Ave, New York 10022
(212) 848-4831, (646) 848-4831

Licenses:

New York - Due to reregister within 30 days of birthday 2001

Education:

University of Virginia School of LawDegree JD - Juris Doctor - Law

Specialties:

Intellectual Property - 100%

Partner At Shearman And Sterling

Position:

Partner at Shearman and Sterling

Location:

Greater New York City Area

Industry:

Law Practice

Work:

Shearman and Sterling since Nov 2003 - Partner Clifford Chance US LLP Sep 2000 - Nov 2003 - Associate

Education:

University of Virginia School of Law 1997 - 2000
JD University of Virginia 1993 - 1997
BA

Compositions And Methods For Disrupting The Function Of The Transcriptional Repressor Component Sin3A-Pah2 Domain To Induce Differentiation And Growth Inhibition In Breast Cancer

US Patent:

2011000, Jan 6, 2011

Filed:

Jun 1, 2010

Appl. No.:

12/791356

Inventors:

SAMUEL WAXMAN - NEW YORK NY, US
EDUARDO FARIAS - NEW YORK NY, US

Assignee:

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION - NEW YORK NY
C/O SAMUEL WAXMAN CANCER RESEARCH FOUNDATION - NEW YORK NY

International Classification:

A61K 38/10, C07K 7/08, C07K 14/435, A61K 38/17, A61P 35/00

US Classification:

514 194, 530327, 530326, 530325, 530324

Abstract:

The present invention relates, generally, to compositions for treating breast cancer, use of the compositions to sensitize breast cancer cells to treatment, and methods for treating breast cancer by administering the compositions. The compositions comprise peptides derived from the mSin3A interaction domain (SID) and derivatives thereof, as well as small molecule inhibitors (SMIs) capable of interfering with interactions between SID and the paired amphipathic helix domain 2 (PAH2) domain of the transcription repressor Sin3A. The present invention further relates to compositions for treating triple-negative breast cancer, use of the compositions to render the breast cancer cells susceptible to treatment using hormonal therapies and HER2-based therapies, and methods for treating triple-negative breast cancer by administering the compositions.